A critical limitation of bioorthogonal click chemistry for in vivo applications has been its low reaction effi ciency due to the pharmacokinetic barriers, such as blood distribution, circulation, and elimination in living organisms. To identify key factors that dominate the effi ciency of click chemistry, here a rational design of near-infrared fl uorophores containing tetrazine as a click moiety is proposed. Using trans -cyclooctene-modifi ed cells in live mice, it is found that the in vivo click chemistry can be improved by subtle changes in lipophilicity and surface charges of intravenously administered moieties. By controlling pharmacokinetics, biodistribution, and clearance of click moieties, it is proved that the chemical structure dominates the fate of in vivo click ligation.
A critical limitation of bioorthogonal click chemistry for in vivo applications has been its low reaction effi ciency due to the pharmacokinetic barriers, such as blood distribution, circulation, and elimination in living organisms. To identify key factors that dominate the effi ciency of click chemistry, here a rational design of near-infrared fl uorophores containing tetrazine as a click moiety is proposed. Using trans -cyclooctene-modifi ed cells in live mice, it is found that the in vivo click chemistry can be improved by subtle changes in lipophilicity and surface charges of intravenously administered moieties. By controlling pharmacokinetics, biodistribution, and clearance of click moieties, it is proved that the chemical structure dominates the fate of in vivo click ligation.
been attributed in part to the binding of serum proteins to click components. In addition, the pharmacokinetic barriers, such as blood distribution, circulation, and elimination as well as biodistribution and clearance, make it diffi cult for the click moieties to reach a target. [ 7 ] To improve the click effi ciency in vivo, the Weissleder et al. introduced large molecular weight polymers, which increased the circulation time of click moieties in the blood vessels and eventually improved click reaction effi ciency. [ 7 ] Although polymer-modifi ed tetrazine (Tz) components facilitated the cycloaddition reaction with the counterpart trans -cyclooctene (TCO) by giving enough reaction time at high concentration, this approach could result in high background retention and limited transportation through the physiological barriers (e.g., blood-brain/nerve barriers and endothelial/intestinal walls). [ 8 ] Thus, small molecules are still attractive for in vivo reactions due to their rapid secretion rates and low potential side effects. [ 9 ] However, the key factors regulating in vivo click chemistry of small molecules have not been fully understood.
Previously, we have studied the pharmacokinetics of nanoparticles and small molecules in various animal models, and defi ned the physicochemical properties such as size, surface charge, and lipophilicity that play a key role in targeting and imaging. [ 10 ] Very recently, we have developed a novel concept of targeted contrast agents (i.e., structure-inherent targeting), where the inherent chemical structure governs the fate of an injected molecule and the ultimate targeting to specifi c organs such as thyroid/parathyroid glands, [ 10 ] bone, [ 11 ] and cartilage. [ 12 ] Using this concept, we could achieve signifi cantly reduced background tissue retention and nonspecifi c uptake in the reticuloendothlial system, and thus improve the signal-to-background ratio (SBR) of the target. [ 10, 13 ] Armed with this strategy, we hypothesized that the effi cacy of bioorthogonal chemistry in vivo would be largely dependent on the inherent chemical structure of systemically administered molecules, where biodistribution and pharmacokinetics need to be controlled.
Herein, we describe a series of novel pentamethine nearinfrared (NIR) fl uorophores composed of three main domains: (1) Tz for click chemistry, (2) pentamethine core for NIR fl uorescence imaging, and (3) variable charges for pharmacokinetic modulation ( Figure 1 ). The Tz-containing NIR fl uorophores were rationally designed to have assorted side groups (R 1 and R 2 ) with varying charges by two, resulting in diverse lipophilicity (Figures S1-S3, Supporting Information). We selected
Introduction
Copper-free click chemistry is ideal for in vivo bioorthogonal reactions due to its fast and facile chemical process with little cellular toxicity. [ 1 ] Despite its potential in bioimaging and nanomedicine including optical imaging, [ 2 ] positron emission tomography (PET), [ 3 ] single-photon emission computed tomography (SPECT), [ 4 ] ultrasound imaging, [ 5 ] and drug delivery, [ 6 ] in vivo click chemistry in the past decade has suffered from relatively low reaction effi ciency. This problem has
Results and Discussion
We modifi ed surface charges of the pentamethine core to obtain the fi nal Tz-fl uorophores with distinctive physicochemical properties such as logD at pH 7.4 (distribution coeffi cient), TPSA (topological polar surface area), HBA (hydrogen bond acceptor), and p K a (acid dissociation constant). Compounds 4 with assorted charges were conjugated to amine-functionalized Tz through the conventional N -hydroxysuccimide (NHS) chemistry, and the fi nal products were characterized by liquid chromatography-mass spectrometry (LC-MS) ( Figure S4 , Supporting Information). Based on the total net charges, we named each fl uorophore as Tz−3, Tz−1, Tz+1, and Tz+3 (Figure 1 b) . The maximum absorption and emission wavelengths are in the NIR window ( Figure S5 , Supporting Information), where the combined absorption of NIR light and water/hemoglobin is minimal in addition to low autofl uorescence. [ 14 ] Physicochemical properties were calculated based on the fi nal chemical structure using MarvinSketch 6.1.4 (ChemAxon), and optical properties were measured by using spectrophotometers (Ocean Optics). As shown in Figure 1 c, logD values of Tz-fl uorophores increase in the order of Tz+3 < Tz−3 < Tz+1 < Tz−1, representing their lipophilicity under physiological conditions. However, both TPSA and HBA values showed a different trend for Tz+3 < Tz+1 = Tz−1 < Tz−3 because the sulfonate group has a high electron density and multiple sites for hydrogen bonding. Acidic p K a values represent that sulfonates are deprotonated under the physiological condition. The maximum excitation and emission wavelengths of all 4 Tz-fl uorophores were similar in the NIR window. However, the introduction of different surface charges resulted in varying extinction coeffi cients and quantum yields due to the altered resonance of electrons in the pentamethine core (Figure 1 c) . To minimize the difference in molecular brightness, we adjusted the imaging exposure time for individual images based on the brightness obtained from in vitro and in vivo studies.
To validate the click effi ciency in vitro, we treated B16F10 murine melanoma cells with TCO-PEG 4 -NHS resulting in TCO-modifi ed cells by conjugating NHS esters to the amines of proteins on the cell surface. [ 15 ] Then, we treated each Tzfl uorophore to those TCO-modifi ed cells at a concentration of 2 × 10 −6 M in growth media. After 10 min incubation at 37 °C, all Tz-fl uorophores exhibited over 15-fold higher fl uorescence signals in TCO-modifi ed cells compared with control cells where no TCO groups exist on the cell surface ( Figure 2 a) . [ 16 ] Although surface charges and lipophilicity cause immediate serum protein binding in cellular media and in the body, positively charged Tz+3 showed the fastest click reaction due to the thermodynamically favorable interactions between the cationic charges of Tz+3 and negatively charged cell surface. On the other hand, Tz−1 representing high lipophilicity (logD at pH 7.4 = 3.0) exhibited a relatively slow Tz-TCO reaction due to the low reaction concentration of fl uorophores resulted from microaggregation. Tz−1, however, reached its steady state ( V max ) similar to the others at 10 min post-incubation, which represents the highly effi cient click reactivity of Tz-fl uorophores against TCO groups (Figure 2 b) . Interestingly, the reaction rate of Tz−1 was enhanced in serum-free media because of enriched binding of ligands to the cell surface without serum protein competition ( Figure S6 , Supporting Information).
Then, we evaluated how the altered chemical structure of fl uorophores affects the pharmacokinetics, blood circulation, and biodistribution in vivo. 10 nmol of each fl uorophore was injected intravenously into C57BL/6J mice while exposing abdominal wall and major organs under the surgical fi eld, and the biodistribution and clearance of each fl uorophore were observed by an intraoperative imaging system [ 10 ] for 4 h while collecting blood samples using capillary tubes ( Figure 3 a) . Given the pharmacokinetics of Tz-fl uorophores, all molecules distributed rapidly in the bloodstream, but cleared differently from the major organs. As shown in Figure 3 b, the distribution half-life ( t 1/2α ) of Tz−3 and Tz+3 was about 3-4-fold longer than that of Tz−1 and Tz+1. It shows that blood circulation is closely related to the physicochemical properties of each injected fl uorophore, especially the surface charge and logD values as described in Figure 1 . [ 17, 18 ] The terminal half-life ( t 1/2β ) of Tz-fl uorophores followed a slightly different trend, showing a wide range of values depending on the lipophilicity. Interestingly, the t 1/2β of Tz−1 is about 10-fold longer than the others, mainly because the lipophilic character promotes spontaneous binding to serum proteins, which drives the dye-protein complex mostly into the hepatobiliary clearance route (Figure 3 c and Figure S7 , Supporting Information). [ 17 ] The rest of Tz-fl uorophores followed both renal and hepatobiliary excretion as depicted in the biodistribution and clearance data observed by real-time intraoperative fl uorescence imaging ( Figure S7¸ Supporting Information). The other physiological and pharmacokinetic factors such as the area under the plasma concentration-time curve (AUC), volume of distribution ( V d ), and plasma clearance were dependent on blood half-life values, although their extravasation rates are considered to be similar. [ 19 ] However, the enhanced AUC and V d of Tz−1 were resulted from the high logD value (3.0 at pH 7.4), which contributed to tissue penetration, especially to the liver. The logD values of Tz−3 and Tz+3 are similar (−2.7 vs −3.2 at pH 7.4) and thus showed similar biodistribution, while Tz+3 with cationic charges required a longer elimination time compared to Tz−3 due to the delayed secretion caused by nonspecifi c ionic adhesion to the negatively charged cell surface. [ 20 ] We observed a similar trend in the resected tissues from the mice sacrifi ced at 4 h post-injection of Tz-fl uorophores, which was quantifi ed by the SBR of each major organ against surrounding muscle tissue ( Finally, we determined the effect of the physicochemical properties and pharmacokinetics on the effi ciency of click chemistry in vivo. We prepared TCO-modifi ed B16F10 cells as described above and administered into syngeneic C57BL/6J mice intravenously to deposit them in lung capillaries, as previously reported. [ 21 ] After 30 min, we injected each Tz-fl uorophore to those TCO-presenting mice intravenously. After 4 h post-injection of Tz-fl uorophores, animals were sacrifi ced and lung tissue was harvested to analyze the effi ciency of in vivo click reaction by comparing fl uorescence signals at 700 nm (NIR #1). Since cells were pre-labeled with an 800 nm emitting lipophilic fl uorophore CTNF126 (NIR #2), the signals from Tz-fl uorophores could be normalized based on the 800 nm emitting cell signals to minimize the potential errors resulting from different cell numbers deposited in the lung. Notably, Tz-fl uorophores represented signifi cantly higher signals in the lungs of TCO presenting mice compared to control mice administered with bare cells treated without TCO groups ( Figure 4 a) .
The SBR of Tz−1 and Tz+1 were relatively low (1.42 and 1.09, respectively), which represents less effi cient in vivo click chemistry (Figure 4 b ). This could be because of short t 1/2 α and insuffi cient contact time of Tz−1 and Tz+1 fl uorophores with the TCO-modifi ed cells in lungs, resulted from rapid nonspecifi c uptake into liver (Tz−1) and kidneys (Tz+1) during the systemic circulation. In contrast, highly hydrophilic Tz−3 and Tz+3 exhibited high SBR (2.53 and 4.24, respectively) in the lung, representing favorably enhanced click reactions in vivo. These results emphasize the importance of defi ning the distribution half-life as a critical pharmacokinetic parameter, which refl ects the amount of Tz-fl uorophores reaching the target cells in a reliable manner (Figure 4 c) .
In addition, the reduced lipophilicity and longer circulation contributed signifi cantly to the molecular interactions in vivo as reported previously. [ 18, 22 ] Thus, we proved that the small molecule click moieties with optimized molecular properties could enhance bioorthogonal chemistry in vivo without using a large carrier (i.e., polymers or nanoparticles). Interestingly, Tz+3 outperformed Tz−3 with >50% higher click reactivity in vivo, while exhibiting only 20% longer distribution half-life. This is conceivably because the multiple positive surface charges have a profound effect on cellular accessibility in the luminal and interstitial spaces, which increase the chances for bioorthogonal click reaction in vivo. [ 23 ] This result is in accordance with the previous report by Dearling and Packard where Cu-chelators with different surface charges changed their biodistribution signifi cantly. [ 24 ] The reaction rate between the two chemicals, especially in the intravenous injection, is important because the contact time is limited by blood fl ow and/or active secretion processes in the body. The reaction rate constant of original azide-alkyne click chemistry has been reported to be about 10-100 M −1 s −1 ( k obs ) per 10-100 × 10 −6 M Cu(I) catalyst ( Table 1 ) . [ 25 ] Strained alkynes without copper showed about 1000-fold slower click reaction (1-140 × 10 −3 M −1 s −1 ), [ 26 ] while the Tz-TCO reaction has been reported as fast as 6 × 10 3 M −1 s −1 , [ 27 ] which is one of the fastest copper-free click reactions reported in literature. However, considering the association rate constant of biological ligands to their receptors (e.g., Nimotuzumab and epidermal growth ), [ 28 ] click chemistry is still slower than other biological binding processes.
Therefore, the longer circulation time of click moieties is particularly important to enhance the effi ciency of in vivo click reactions. In addition, the combination of cationic charges and low logD (non-lipophilicity) of intravenously injected ligands played the critical role to improve surface click chemistry. However, it should be noted that other target models and biological ligands could be dependent on the correlative response to the distribution half-life, where the click moieties need to be reoptimized to fi t into the particular model system. For instance, zwitterionic or anionic charged small molecules show relatively short terminal half-life values and high volume of distribution due to the limited tissue penetration, which might be better candidates for peripheral tissue targets with considering other physiological and pharmacokinetic factors preferentially. 
Conclusion
In summary, we have identifi ed that surface charges and lipophilicity of injected molecules play the key role to achieve high reaction effi ciency in bioorthogonal click chemistry. Despite the differences in physicochemical properties, all 4 Tz-fl uorophores offered preferentially fast click reactions with TCO-modifi ed cells in vitro within 10 min in biological media. However, their pharmacokinetics and biodistribution in animals were dependent upon the chemical structure, which governed the fi nal click effi ciency in vivo. These newly developed Tz-fl uorophores can be used to label various biomaterials including nucleotide, protein, cells, and nanoparticles to control site-specifi c click reaction. Considering the applicability of copper-free click chemistry, the rationally designed chemical structures to control pharmacokinetics and biodistribution will lay the foundation of new-targeted contrast agents for optical, magnetic resonance, and nuclear imaging.
Experimental Section
Synthesis and Characterization of Tz-Fluorophore : Tz-amine ((4-(1,2,4,5-tetrazin-3-yl)phenyl)methanamine hydrochloride) was purchased from Sigma-Aldrich (St. Louis, MO). TCO-PEG 4 -NHS ( trans -cyclooctene-polyethylene glycol 4 -N -hydroxysuccinimide ester) was purchased from Clickchemistrytools (Scottsdale, AZ). All other chemicals were purchased from Fisher Scientifi c (Pittsburgh, PA), Sigma-Aldrich (Saint Louis, MO) or Acros Organics (Morris Plains, NJ). Pentamethine fl uorophores with assorted side groups were synthesized fi rst, and they were conjugated with Tz-amine. Briefl y, indols and bromides with different side groups were conjugated each other, and they were conjugated with Vilsmeier-Haack reagent to form pentamethine core. Then, 4-(2-carboxyethyl)phenylboronic acid were also conjugated to the intermediate to obtain additional acid group for further modifi cation. Finally, the compounds were conjugated with Tz-amine through the conventional NHS chemistry. See Supporting Information for detailed chemical syntheses and analysis.
In Vitro Binding Assay of Tz-Fluorophores to TCO-Modifi ed Cells : B16F10 murine melanoma cells were purchased from ATCC (Manassas, VA). Cells were maintained in DMEM (Gibco, Grand Island, NY), supplemented with 10% fetal bovine serum (FBS; Gibco), 100 U mL −1 penicillin and 100 µg mL −1 streptomycin (Gibco) at 37 °C in a humidifi ed 5% CO 2 atmosphere. B16F10 cells were seeded onto four-chamber glass bottom dish at a density of 1 × 10 5 cells per chamber in 1 mL full growth media. After overnight incubation, they were incubated with TCO-PEG 4 -NHS (20 × 10 −6 M in 1 mL PBS containing Ca 2+ and Mg 2+ ) for 30 min, followed by washing with PBS (pH 7.4) twice, they were further incubated with Tz-fl uorophores (2 × 10 −6 M in 1 mL full growth media) and Hoechst 33342 (Invitrogen, Carlsbad, CA) for varied time periods. Cellular images were obtained using a FV1000 multi-photon confocal microscope (Olympus, Tokyo, Japan) equipped with Laser Diode (405 and 633 nm) after washing and fi xation with 2% formaldehyde solution for 5 min.
In Vivo Biodistribution and Pharmacokinetics of Tz-Fluorophores : Animals were housed in an AAALAC-certifi ed facility and were studied under the supervision of BIDMC IACUC in accordance with the approved institutional protocol (#057-2014). Six weeks old C57BL/6 mice (male; 20-25 g) were purchased from Charles River Laboratories (Wilmington, MA). Animals were anesthetized with 100 mg kg −1 ketamine and 10 mg kg −1 xylazine intraperitoneally (Webster Veterinary, Fort Devens, MA). 10 nmol of the Tz-fl uorophores in saline were administered intravenously, and animals were imaged using the real-time intraoperative dual-NIR channel imaging system. [ 10 ] Herein, 670 nm excitation light (1 mW cm −2 ) and 760 nm excitation light (4 mW cm −2 ) were used with white light (400-650 nm) at 40 000 lux. Color and NIR fl uorescence images were acquired simultaneously with custom software at rates of up to 15 Hz over a fi eld of view with a diameter of 15 cm. For each experiment, camera exposure time and image normalization was held constant. To quantify the distribution ( t 1/2 α) and elimination ( t 1/2 β) blood half-life values, intermittent sampling from the tail vein was performed over the 4 h period following a single intravenous administration. Approximately 10-20 µL of blood were collected using glass capillary tubes at the following time points: 0, 3, 5, 10, 30, 60, 120, and 240 min. The same intraoperative imaging system was used to measure the fl uorescence intensity of each sample, and the concentration was calculated based on the image SBR using a standard curve for each fl uorophore. Animals were injected with Tz-fl uorophores 4 h prior to imaging, and major organs were resected, imaged, and the signal from each organ/tissue was quantifi ed by measuring fl uorescent intensity (photons s −1 cm −2 sr −1 ). At least three animals were analyzed at each time point. Results were presented as mean ± s.d. and curve fi tting was performed using Prism version 4.0a software (GraphPad, San Diego, CA).
In Vivo Click Chemistry between Tz-Fluorophores and TCO-Modifi ed Cells : TCO-modifi ed B16F10 cells were prepared as above and stained with an 800 nm emitting lipophilic cation CTNF126 for 30 min incubation. After detachment of labeled cells with cell scraper, the TCO-modifi ed cells (1 × 10 6 cells per mouse) were injected intravenously into C57BL/6 mice. 10 nmol of each Tz-fl uorophore in saline were administered intravenously into the same mice 30 min post-injection of cells. Animals were sacrifi ced 4 h post-injection of Tz-fl uorophores, and lungs were resected, imaged, and analyzed by using the custom-built imaging system.
Quantitative Analysis : The fl uorescence and background intensity of a region of interest over each tissue was quantifi ed using custom imaging software and ImageJ v1.48 (NIH, Bethesda, MD). The SBR was calculated as SBR = fl uorescence/background, where background is the signal intensity of muscle. All NIR fl uorescence images for a particular Tz-fl uorophore were normalized identically for all conditions of an experiment. A one-way ANOVA followed by Tukey's multiple comparisons test were used to assess the statistical differences between multiple groups. A P-value of less than 0.05 was considered signifi cant: * P < 0.05, ** P < 0.01, and *** P < 0.001. Results are presented as mean ± standard deviation (s.d.).
Supporting Information
Supporting Information is available from the Wiley Online Library or from the author. 
Supplementary Methods
Materials: All chemicals and solvents were of American Chemical Society grade or HPLC purity and were used as received. HPLC grade acetonitrile (CH 3 CN) and water were purchased from VWR International (West Chester, PA) and American Bioanalytic (Natick, MA), respectively. Tz-amine ((4-(1,2,4 ,5-tetrazin-3-yl)phenyl)methanamine hydrochloride) was purchased from Sigma-Aldrich (St. Louis, MO). TCO-PEG 4 -NHS (trans-cyclooctenepolyethylene glycol 4 -N-hydroxysuccinimide ester) was purchased from Click chemistry tools (Scottsdale, AZ). All other chemicals were purchased from Fisher Scientific (Pittsburgh, PA), Sigma-Aldrich and Acros Organics.
The reactions were followed using silica gel 60 F 254 thin layer chromatography plates (Merck EMD Millipore, Darmstadt, Germany). Open column chromatography was utilized for the purification of all hydrophobic final compounds using 60-200 µm, 60Å classic column silica gel (Dynamic Adsorbents, Norcross, GA). Highly charged final products were isolated using revered phase C18 column chromatography (Fluka).
1 H NMR spectra were obtained using high Compound 5 2-((1E,3Z,5Z)-
2-((1E,3Z,5E)-3-(4-(2-carboxyethyl)phenyl)-5-(3,3-dimethyl-5-sulfonato-1-(4-sulfonatobutyl)-indolin-2-ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(4-sulfonatobutyl)-3H-indol-1-ium-5-sulfonate (Compound 5).
(160 mg), 3-(4-boronophenyl)propanoic acid (60.8 mg) and cesium carbonate (30.2 mg) was stirred in water and to this solution was added tetrakis(triphenylphosphine)palladium (0) (10%).
The reaction mixture was heated to reflux for 3 days. The mixture was cooled to room temperature and filtered then the filtrate was concentrated under reduced pressure to give a crude product as blue residue. The crude was loaded on a reverse phase column and eluent with MeOH in water to give the product 5. Yield 34%; mp 285°C (decomposed 
3-((E)-2-((2Z,4E)-3-(4-(2-carboxyethyl)phenyl)-5-(3,3-dimethyl-1-(3-sulfonatopropyl)-3H-indol-

1-ium-2-yl)penta-2,4-dien-1-ylidene)-3,3-dimethylindolin-1-yl)propane-1-sulfonate (Compound
6).
borono-phenyl)propanoic acid (103.2 mg) and cesium carbonate (48.15 mg) was stirred in water and THF (1:1) and to this solution was added tetrakis(triphenylphosphine)palladium (0) (10%).
The reaction mixture was refluxed for 3 days and cooled to room temperature. The mixture was filtered and solvents were evaporated. The crude product was separated by reverse phase column chromatography to afford the pure final compound 6 (45 mg). Yield 25%; mp > 268°C. 1 
3-(4-((1E,3Z,5E)-1-(3,3-dimethyl-5-sulfonato-1-(3-(trimethylammonio)propyl)-3H-indol-1-ium-
2-yl)-5-(3,3-dimethyl-5-sulfonato-1-(3-(trimethylammonio)propyl)indolin-2-ylidene)penta-1,3- dien-3-yl)phenyl)
Compound 11
To a solution of the 2-((1E,3Z,5E)- 
3-(4-((1E,3Z)-1-(3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-indol-1-ium-2-yl)-5-((E)-3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-2-ylidene)penta-1,3-dien-3-yl)phenyl)-
propanoate (Compound 12) . 
Compound 12
To a solution of 2- ((1E,3Z) 
3H-indol-1-ium 10 (1.15 mmol), 4-(2-carboxyethyl)phenylboronic acid (2.32 mmol) and cesium carbonate (3 mmol) in a mixture of EtOH (15 mL) and water (15 mL) under N 2 at room temperature, was added tetrakis(triphenyl phosphine)palladium (0) (0.1 mmol) and the reaction mixture was stirred at 60°C for 4 h while monitoring by Vis/NIR spectrophotometry and alumina TLC plates eluting with 1% methanol in dichloromethane. After the reaction was finished as indicated by the consumption of starting bromo compound, the solvent was evaporated under vacuum and the residue was purified by precipitation from methanol using diethyl ether. Several precipitations and washing with acetone, ether and ethyl acetate afforded the final purified compound 12 as a blue-green solid. Yield 57%; mp > 220°C. 1 
2-((1E,3Z,5E)-3-(4-(3-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-3-oxopropyl)phenyl)-5-(3,3-
dimethyl-5-sulfonato-1-(4-sulfonatobutyl)indolin-2-ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(4-sulfonatobutyl)-3H-indol-1-ium-5-
3-((E)-2-((2Z,4E)-3-(4-(3-((
4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-3-oxopropyl)phenyl)-5-(3,3- dimethyl-1-(3-sulfonatopropyl)-3H-indol-1-ium-2-yl)penta-2,4-dien-1-ylidene)-3,3- dimethylindolin-1-yl)propane
2-((1E,3Z,5E)-3-(4-(3-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-3-oxopropyl)phenyl)-5-(3,3-dimethyl-5-sulfonato-1-(3-(trimethylammonio)propyl)indolin-2-ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-indol-1-ium-5-sulfonate
2-((1E,3Z,5E)-3-(4-(3-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-3-oxopropyl)phenyl)-5-(3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-2-ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-indol-1-ium
